Factors in Gestational Diabetes Mellitus Predicting the Needs for Insulin Therapy

Ya Zhang, Jiashen Shao, Feifei Li, Xianming XuInternational Journal of Endocrinology 2016 · DOI

TL;DR

This study identifies key predictors for insulin therapy need in pregnant women with Gestational Diabetes Mellitus (GDM). By analyzing data from over 1300 patients, researchers found that higher fasting blood glucose levels during the oral glucose tolerance test (OGTT), elevated 2-hour glucose levels post-OGTT, and higher HbA1c at diagnosis are strong indicators for requiring insulin. This insight can help clinicians better anticipate and manage GDM cases needing more intensive treatment.

What Problem Does This Paper Address?

Gestational Diabetes Mellitus (GDM) is a common pregnancy complication characterized by carbohydrate metabolism disorders. While lifestyle interventions like medical nutrition therapy (MNT) and exercise are the first line of treatment, a significant portion of women with GDM eventually require insulin therapy to maintain adequate glycemic control. Identifying which patients are more likely to need insulin early on is crucial for optimizing care, preventing complications, and ensuring better maternal and fetal outcomes. This paper aims to pinpoint specific factors that predict this need, allowing for more proactive management strategies.

Methods

The researchers conducted a retrospective study involving 1352 pregnant women diagnosed with GDM. They employed a combination of statistical analyses:

  • Univariate Analysis: This was used to compare clinical variables and characteristics between two groups: those who required insulin therapy (AIT) and those managed solely with MNT.
  • Multivariate Stepwise Logistic Regression: This advanced technique was used to identify independent predictors of insulin therapy need from a set of variables. The "stepwise" nature means variables are added or removed from the model based on their statistical significance.
  • Receiver Operating Characteristic (ROC) Curve Analysis: ROC curves were generated to assess the diagnostic value of identified predictors. This helps determine the optimal cutoff points for these predictors to distinguish between patients who will and will not need insulin.

Datasets

The study utilized data from 1352 pregnant women diagnosed with GDM at Shanghai First People's Hospital between January 2009 and December 2012. This dataset was collected retrospectively.

Key Insights and Ideas

  • Predictive Power of OGTT and HbA1c: The study strongly suggests that specific glucose measurements from the OGTT (fasting and 2-hour post-glucose) and the HbA1c level at diagnosis are not just indicators of GDM severity but also robust predictors of the need for insulin.
  • Early Identification for Proactive Care: By identifying these predictors, clinicians can potentially flag high-risk patients earlier, allowing for more intensive monitoring or a quicker transition to insulin therapy if MNT alone proves insufficient.
  • Ethnic Differences Matter: The paper notes that the proportion of women requiring insulin therapy in their study (44.8%) was higher than reported in some other studies (e.g., ACHOIS study at 20%). They attribute this, in part, to potential ethnic differences in GDM prevalence and response to treatment, highlighting the need for context-specific interpretation of results.
  • Obesity as a Contributing Factor, Not a Sole Predictor: While obesity showed a significant difference between the AIT and MNT groups in univariate analysis, it did not emerge as an independent predictor in the multivariate model. This suggests it's a contributing factor but not the primary driver for insulin need in this cohort.

Key Results

  • Independent Predictors: Multivariate analysis identified higher fasting blood glucose at OGTT, higher 2-hour plasma glucose during OGTT, and higher HbA1c concentration at diagnosis as independent predictors for the need for insulin therapy.
  • Odds Ratios (ORs): For each unit increase in these predictors, the odds of needing insulin therapy increased:
  • Pregestational BMI: 1.08 (95% CI, 1.03-1.13)
    • FBG at time of OGTT: 2.02 (95% CI, 1.65–2.47)
    • HbA1c at time of OGTT: 1.90 (95% CI, 1.46-2.47)
    • OGTT 2h plasma glucose: 1.16 (95% CI, 1.07–1.27)
  • Diagnostic Thresholds: The study proposed cutoff values for predicting insulin need:
  • FBG at time of OGTT ≥ 5.69 mmol/L (AUC: 0.80)
    • HbA1c at time of OGTT ≥ 5.85% (AUC: 0.77)
    • OGTT 2h plasma glucose ≥ 10.8 mmol/L (AUC: 0.73)
  • Pre-pregnancy BMI: While showing a significant difference between groups, pregestational BMI did not have significant diagnostic value (AUC: 0.508, P > 0.05).

Limitations and Future Work

  • Retrospective Design: The study's retrospective nature limits control over factors like dietary compliance, which can influence glycemic control.
  • Unmeasured Factors: Unaccounted fetal or placental factors that affect insulin resistance could also play a role.
  • Low Positive Predictive Value: The authors acknowledge that the identified predictors, while useful, have relatively low positive predictive values and are not entirely specific for insulin treatment.
  • Testing Window: While the study's OGTT testing window (24-34 weeks) was slightly broader than current guidelines (24-28 weeks), they believe it did not significantly compromise the results.
  • Future Work: The paper suggests that recognizing patient characteristics that predict MNT failure early can help diabetes teams prioritize care and resource allocation, implying a need for further research into integrating these predictors into clinical decision-making tools.

Summary updated

Abstract

Objective. To identify factors predicting the need for insulin therapy in pregnancies complicated by gestational diabetes mellitus (GDM). Methods. A total of 1352 patients with GDM diagnosed by the 75-g/2-h oral glucose tolerance test (OGTT) were enrolled in this study. Univariate and multivariate analysis were performed; receiver operating characteristics (ROC) were also drawn. Results. There was a significant difference in factors such as maternal age, pregestational BMI, first visit SBP, first visit DBP, FBG of first visit, FBG at time of OGTT, 75-g OGTT glucose value (fasting, after 1 h and 2 h), and serum HbA1c level at diagnosis between patients with insulin therapy and patients with medical nutrition therapy (MNT) alone. Multivariate analysis showed that higher FBG at time of OGTT, first 75 g OGTT 2 h plasma glucose, and HbA1c concentration at diagnosis lead to more likely need of insulin therapy. Conclusion. The probability of insulin therapy can be estimated in pregnant women with GDM based on fasting and 2 h glucose values during OGTT and HbA1c value at diagnosis of GDM.
BibTeX
@article{zhang2016factors,
  author = {Ya Zhang and Jiashen Shao and Feifei Li and Xianming Xu},
  title = {{Factors in Gestational Diabetes Mellitus Predicting the Needs for Insulin Therapy}},
  journal = {International Journal of Endocrinology},
  year = {2016},
  doi = {10.1155/2016/4858976},
}
Figure